Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anastrozole Extension for Pubertal Gynecomastia
NCT00637182Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2001
- Primary completion
- Jun 2002
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
01
Overview
A Phase 3 trial of anastrozole in gynecomastia, sponsored by AstraZeneca. Started Jan 2001; status: completed.
02
Drugs
anastrozole
03
Conditions
gynecomastia
Beyond the preview
Go deeper on NCT00637182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00637182.